Sex differences in ambulatory visits for chronic obstructive pulmonary disease, based on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey from 1995 to 2004

Respiratory Care

Volumn 53, Issue 11, 2008, Pages 1461-1469

  Suh, Dong Churl ^a   Lau, Helen ^b   Pokras, Shibani M ^b   Choi, In Sun ^a   Valiyeva, Elmira ^c  

^a RUTGERS UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic obstructive pulmonary disease; NAMCS; National Ambulatory Medical Care Survey; National Hospital Ambulatory Medical Care Survey; NHAMCS

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; EXPECTORANT AGENT; METHYLXANTHINE; MUCOLYTIC AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMORBIDITY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PHYSICIAN; PRESCRIPTION; SEX DIFFERENCE; TREND STUDY; COMPARATIVE STUDY; EPIDEMIOLOGY; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SEX RATIO; STATISTICS; UTILIZATION REVIEW;

AGED; AMBULATORY CARE; AMBULATORY CARE FACILITIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SEX FACTORS;

EID: 58849146720     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004;25(2):331-341.
2. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121(5 Suppl):121S-126S.
3. Lindberg A, Jonsson AC, Rönmark E, Rundgren R, Larsson LG, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005;127(5):1544-1552. (Pubitemid 46222236)
4. Mulroy J. Chronic obstructive pulmonary disease in women. Dimens Crit Care Nurs 2005;24(1):1-20.
5. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 2003;48(12):1185-1191.
6. National Heart Lung and Blood Institute. Morbidity and mortality: 2007 chartbook on cardiovascular, lung, and blood diseases. June 2007. http://www.nhlbi.nih.gov/resources/docs/07-chtbk.pdf. Accessed September 10, 2008.
7. Rascati KL, Stanford RH, Borker R. A comparison of the risk of hospitalizations due to chronic obstructive pulmonary disease in Medicaid patients with various medication regimens, including ipratropium inhaled corticosteroids, salmeterol, or their combination. Clin Ther 2005;27(3):346-354. (Pubitemid 40692754)
8. Donnelly LE, Rogers DF. Therapy for chronic obstructive pulmonary disease in the 21st century. Drugs 2003;63(19):1973-1998. (Pubitemid 37229086)
9. Jiménez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante, Sobradillo V. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001;119(5):1365-1370. (Pubitemid 32686016)
10. Watson L, Vestbo J, Postma DS, Decreamer M, Rennard S, Kiri VA, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004;98(12):1207-1213. (Pubitemid 39497223)
11. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10(2):98-103. (Pubitemid 38402535)
12. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119(6):1691-1695. (Pubitemid 32744923)
13. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance, United States, 1971-2000. MMWR Surveill Summ 2002;51(6);1-16.
14. Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride NB. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000;55(9):789-794. (Pubitemid 30660909)
15. Centers for Disease Control and Prevention; National Ambulatory Medical Care Survey (NAMCS). http://www.cdc.gov/nchs/about/major/ahcd/ahcd1.htm. Accessed September 10, 2008.
16. Centers for Disease Control and Prevention; National Hospital Ambulatory Medical Care Survey (NHAMCS). http://www.cdc.gov/nchs/about/major/ahcd/ahcd1. htm. Accessed September 10, 2008.
17. Scholle SH, Chang J, Harman J, McNeil M. Characteristics of patients seen and services provided in primary care visits in obstetrics/gynecology: data from NAMCS and NHAMCS. Am J Obstet Gynecol 2004;190(4):1119-1127. (Pubitemid 38561535)
18. Grant RW, Pirraglia PA, Meigs JB, Singer DE. Trends in complexity of diabetes care in the United State from 1991 to 2000. Arch Intern Med 2004;164(10):1134-1139.
19. Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, Magno Zito J. Prescribing trends in psychotropic medications. JAMA 1998;279(7):526-531.
20. Forrest CB, Whelan EM. Primary care safety-net delivery sites in the United States. JAMA 2000;284(16):2077-2083.
21. Berstein AB, Hing E, Burt CW, Hall MJ. Trend data on medical encounters: tracking a moving target. Health Aff (Millwood) 2001;20(2):58-72. (Pubitemid 33710276)
22. International classification of diseases. 9th revision, clinical modification. Washington, DC: Public Health Service; US Department of Health and Human Services; 2004.
23. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated December 2007. http://www.goldcopd.org/guidelineitem. asp?l1=2&l2=1&intId=989. Accessed September 10, 2008.
24. Bourdet SV, Williams DM. Chronic obstructive pulmonary disease. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach. New York: McGraw-Hill Medical; 2005:537-575.
25. American hospital formulary service drug information. Bethesda, MD: American Society of Health-System Pharmacists; 2005.
26. Agresti A. Categorical data analysis, 2nd edition. New York: John Wiley & Sons; 2002.
27. Greene WH. Econometric analysis, 3rd edition. Upper Saddle River, NJ: Prentice Hall; 1996.
28. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute; 1999.
29. SUDAAN Language Manual, Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
30. Hing E, Gousen S, Shimizu I, Burt C. Guide to using masked design variables to estimate standard errors in public use files of the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Inquiry 2003;40(4):401-415. (Pubitemid 38365288)
31. Kanner RE, Connett JE, Altose MD, Buist AS, Lee WW, Tashkin DP, Wise RA. Gender difference in airway hyperresponsiveness in smokers with mild COPD. Am J Respir Crit Care Med 1994;150(4):956-961.
32. Weiss ST, DeMeo DL, Postma DS. COPD: problems in diagnosis and measurement. Eur Respir J 2003;21(Suppl 41):4S-12S. (Pubitemid 36648149)
33. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, et al. Gender-related differences in severe, early-onset chronic obstructive pulmanary disease. Am J Respir Crit Care Med 2000;162(6):2152-2158. (Pubitemid 32051679)
34. Hollenbeak CS, Weissman CS, Rossi M, Ettinger SM. Gender disparities in percutaneous coronary interventions for acute myocardial infarction in Pennsylvania. Med Care 2006;44(1):24-30.
35. Smith MA, Lisabeth LD, Brown DL, Morgenstern LB. Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neuorology 2005;65(6):855-858. (Pubitemid 41362129)
36. Kapral MK, Devon J, Winter AL, Wang J, Peters A, Bondy SJ. Gender differences in stroke care decision making. Med Care 2006;44(1):70-80.
37. Karlson EW, Daltroy LH, Liang MH, Eaton HE, Katz JN. Gender differences in patient preferences may underlie differential utilization of elective surgery. Am J Med 1997;102(6):524-530. (Pubitemid 27305114)
38. Schatz M, Camargo CA. The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organization. Ann Allergy Asthma Immunol 2003;91(6):553-558. (Pubitemid 38017979)
39. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998;60(2):150-155. (Pubitemid 28160526)
40. Corney RH. Sex differences in general practice attendance and help seeking for minor illness. J Psychosom Res 1990;34(5):525-534. (Pubitemid 20301453)
41. Galdas PM. Men and health help-seeking behaviour: literature review. J Adv Nursing 2004;49(6):616-623.
42. Feenstra TL, Genugten MLL, Hoogenveen RT, Wouters EF, Ruttenvan Mölken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(4):590-596.
43. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10(4):822-827. (Pubitemid 27180193)
44. Machado M, Krishnan J, Buist S, Bilderback AL, Fazolo GP, Santarosa MG, et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174(5):524-529. (Pubitemid 44330544)
45. Halpern MT, Stanford RH, Borker R. The burden of COPD in the U.S.A: results from the confronting COPD survey. Respir Med 2003;97(Suppl C):S81-S89. (Pubitemid 36266873)
46. Zielinski J, Bednarek M, Górecka D, Viegi G, Hurd SS, Fukuchi Y, et al. Increasing COPD awareness. Eur Respir J 2006;27(4):833-852. (Pubitemid 44914210)
47. Dipiro JT, Talbert RL, Yee CC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach, 6th edition. New York; McGraw-Hill; 2005.
48. de Torres JP, Casanova C, Hernández C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005;128(4):2012-2016. (Pubitemid 41507535)
49. Voelkel NF. Raising awareness of COPD in primary care. Chest 2000;117(5 Suppl 2):372S-375S. (Pubitemid 30314469)